Corindus Vascular Robotics, Inc. (CVRS) Financial Statements (2024 and earlier)

Company Profile

Business Address 309 WAVERLEY OAKS ROAD
WALTHAM, MA 02452
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2019
MRQ
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 23,84917,4589,1834,266,60028,5260
Cash and cash equivalents 23,84917,4589,18322,14228,5260
Short-term investments    20,524  
Other undisclosed cash, cash equivalents, and short-term investments    4,223,934  
Receivables 4,5992,8636348784731
Inventory, net of allowances, customer advances and progress billings 2,5082,1031,5451,3291,519
Inventory 2,5082,1031,5451,3291,519 
Other undisclosed current assets 447539448(4,223,343)574 
Total current assets: 31,40322,96311,81045,46431,0921
Noncurrent Assets
Property, plant and equipment 1,7791,4529821,3821,284 
Long-term investments and receivables   142272136 
Due from related parties   71136136 
Accounts and financing receivable, after allowance for credit loss   71136  
Deferred costs     102 
Other undisclosed noncurrent assets 34315179302223
Total noncurrent assets: 2,1221,6031,2031,6841,7443
TOTAL ASSETS: 33,52524,56613,01347,14832,8364
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 6,8836,0534,2572,7373,327236
Employee-related liabilities     185 
Accounts payable 3,5912,4162,4631,5382,005 
Accrued liabilities 3,2923,6371,7941,1991,137 
Other undisclosed accounts payable and accrued liabilities      236
Debt 1,067493,7554,0381,517(47)
Deferred revenue and credits339750701202 
Contract with customer, liability 662
Other undisclosed current liabilities  93  (185)187
Total current liabilities: 8,6126,5348,7627,4764,861376
Noncurrent Liabilities
Long-term debt and lease obligation 10,820102 3,6777,594 
Long-term debt, excluding current maturities 10,774  3,6777,594 
Capital lease obligations 46102    
Liabilities, other than long-term debt 347415181148599 
Deferred revenue and credits342129106531 
Contract with customer, liability 285
Other liabilities 6273524268 
Total noncurrent liabilities: 11,1675171813,8258,193 
Total liabilities: 19,7797,0518,94311,30113,054376
Temporary equity, carrying amount 22,952     
Equity
Equity, attributable to parent, including: (9,206)17,5154,07035,84719,782(372)
Common stock 19191212115
Additional paid in capital 206,165198,337150,776149,489104,648132
Accumulated other comprehensive loss    (14)  
Accumulated deficit (215,390)(180,841)(146,718)(113,640)(84,877) 
Other undisclosed equity, attributable to parent      (509)
Total equity: (9,206)17,5154,07035,84719,782(372)
TOTAL LIABILITIES AND EQUITY: 33,52524,56613,01347,14832,8364

Income Statement (P&L) ($ in thousands)

6/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2014
Revenues 10,7819,6502,8422,7292,98336
Revenue, net9,6502,8422,7292,983 
Cost of revenue (8,673)(9,265)(5,042)(3,724)(5,245)(58)
Cost of goods and services sold (268)(268)  (5,245) 
Other undisclosed gross profit     341 
Gross profit: 2,108385(2,200)(995)(1,921)(22)
Operating expenses (36,415)(34,294)(29,877)(26,176)(19,784)(228)
Other operating income, net
(Other Expenses)
      18
Other undisclosed operating loss      (18)
Operating loss: (34,307)(33,909)(32,077)(27,171)(21,705)(250)
Nonoperating expense (682)(214)(1,001)(1,592)(2,836) 
Investment income, nonoperating     (2,421) 
Other nonoperating expense (682)(214)(1,001)(1,592)  
Interest and debt expense      (18)
Loss from continuing operations: (34,989)(34,123)(33,078)(28,763)(24,541)(267)
Loss before gain (loss) on sale of properties: (34,989)(34,123)(33,078)(28,763)(24,541)(267)
Net loss attributable to parent: (34,989)(34,123)(33,078)(28,763)(24,541)(267)
Preferred stock dividends and other adjustments (7,654)     
Net loss available to common stockholders, diluted: (42,643)(34,123)(33,078)(28,763)(24,541)(267)

Comprehensive Income ($ in thousands)

6/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2014
Net loss: (34,989)(34,123)(33,078)(28,763)(24,541)(267)
Comprehensive loss: (34,989)(34,123)(33,078)(28,763)(24,541)(267)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   14(14)  
Comprehensive loss, net of tax, attributable to parent: (34,989)(34,123)(33,064)(28,777)(24,541)(267)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: